Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Roquefort Investments PLC ( (GB:ROQ) ) has issued an announcement.
Roquefort Therapeutics has announced that its broker, SP Angel Corporate Finance, has published a new research note analysing the company’s proposed transaction with clinical-stage oncology firm Coiled Therapeutics and AI-driven drug discovery specialist A2A Pharmaceuticals. The note, now available via Roquefort’s website, is expected to give investors further insight into the strategic rationale for the deal, which links Roquefort to Coiled’s brain-penetrant cancer candidate AO-252 already in Phase I trials, and to A2A’s generative AI-enabled SCULPT platform and proven spin-out model, potentially strengthening Roquefort’s position in oncology drug development and long-term value creation.
The most recent analyst rating on (GB:ROQ) stock is a Sell with a £1.50 price target. To see the full list of analyst forecasts on Roquefort Investments PLC stock, see the GB:ROQ Stock Forecast page.
Spark’s Take on GB:ROQ Stock
According to Spark, TipRanks’ AI Analyst, GB:ROQ is a Neutral.
The score is primarily held back by weak financial fundamentals (pre-commercial revenue volatility, ongoing losses and cash burn). Technical indicators also point to a sustained downtrend. Low leverage on the balance sheet provides some support, but the negative P/E and lack of dividend yield limit valuation appeal.
To see Spark’s full report on GB:ROQ stock, click here.
More about Roquefort Investments PLC
Roquefort Therapeutics plc is a London-listed biotechnology company focused on developing innovative therapies, operating on the Main Market of the London Stock Exchange. Its activities centre on advancing drug candidates in partnership with other specialist oncology and drug discovery companies, reflecting a strategic focus on cutting-edge cancer treatments and related technologies.
Average Trading Volume: 1,902,120
Technical Sentiment Signal: Sell
Current Market Cap: £1.96M
Find detailed analytics on ROQ stock on TipRanks’ Stock Analysis page.